MetLife, Inc. $MET Shares Purchased by Bessemer Group Inc.

Bessemer Group Inc. grew its position in shares of MetLife, Inc. (NYSE:MET) by 0.5% during the third quarter, Holdings Channel reports. The firm owned 1,979,898 shares of the financial services provider’s stock after acquiring an additional 9,462 shares during the quarter. Bessemer Group Inc.’s holdings in MetLife were worth $163,085,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Norges Bank purchased a new position in MetLife during the 2nd quarter valued at about $756,104,000. Pzena Investment Management LLC lifted its position in shares of MetLife by 6.8% during the second quarter. Pzena Investment Management LLC now owns 9,144,635 shares of the financial services provider’s stock worth $735,412,000 after purchasing an additional 585,671 shares in the last quarter. Invesco Ltd. boosted its stake in shares of MetLife by 2.5% in the second quarter. Invesco Ltd. now owns 6,624,582 shares of the financial services provider’s stock valued at $532,749,000 after purchasing an additional 162,041 shares during the period. Nordea Investment Management AB grew its holdings in shares of MetLife by 2.0% in the third quarter. Nordea Investment Management AB now owns 4,512,620 shares of the financial services provider’s stock valued at $367,643,000 after purchasing an additional 86,519 shares in the last quarter. Finally, Amundi increased its stake in MetLife by 40.2% during the 2nd quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock worth $361,265,000 after buying an additional 1,292,107 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Up 1.5%

MET stock opened at $78.07 on Thursday. The stock has a market cap of $51.44 billion, a P/E ratio of 14.70, a PEG ratio of 0.73 and a beta of 0.77. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $87.39. The company’s 50 day moving average is $78.92 and its two-hundred day moving average is $78.84.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.20. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The business had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $31.43 billion. During the same quarter in the prior year, the business posted $2.08 EPS. The company’s revenue for the quarter was up 27.6% on a year-over-year basis. Research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be issued a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife’s dividend payout ratio (DPR) is presently 42.75%.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Adjusted results beat expectations: MetLife reported adjusted Q4 EPS above consensus and highlighted full‑year adjusted EPS growth and momentum, supporting the company’s profit story. MetLife Announces Full Year and 4Q 2025 Results
• Positive Sentiment: Investment returns helped adjusted quarterly profit rise, a driver for underwriting and investment‑led income that investors view positively. Insurer MetLife Adjusted Quarterly Profit Rises on Strong Investment Returns
• Positive Sentiment: Business mix strength: management cited group benefits and Retirement & Income Solutions (RIS) as contributors to Q4 performance, indicating durable segment-level momentum. MetLife Q4 earnings strengthened by group benefits, RIS units
• Positive Sentiment: Analyst / market commentary sees overall 2025 strength and growth momentum, which can support longer‑term upside versus current multiples. MetLife Reports Strong 2025 Results and Growth Momentum
• Neutral Sentiment: Company provided a CFO video update and slide deck to clarify results and segmentation — useful context but not new guidance. MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video
• Neutral Sentiment: Wider coverage on employee financial wellbeing (MetLife research) and brand recognition may support long‑term franchise value but have limited immediate market impact. The decade that broke employee financial wellbeing, according to MetLife
• Neutral Sentiment: Earnings preview / regional risk watch: analysts are focused on whether Asia growth can offset credit headwinds — a watch item for guidance and reserve assumptions. MetLife earnings on deck: Can Asia growth offset credit headwinds?
• Negative Sentiment: Revenue reporting missed some market estimates: headlines note Q4 revenue came in below certain consensus figures, which raises questions about comparability of metrics reported (PFOs vs. broader revenue measures). MetLife (NYSE: MET) misses Q4 CY2025 revenue estimates
• Negative Sentiment: Third‑party bulletin flagged a significant GAAP EPS and revenue miss (reports a lower diluted EPS and revenues vs. some estimates); the provider notes figures are unverified, but the note likely amplified market concern about GAAP vs. adjusted results. MetLife (MET) Releases Q4 2025 Earnings: Revenue Growth but EPS Miss

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Evercore ISI set a $97.00 price target on shares of MetLife and gave the company an “in-line” rating in a research report on Tuesday, January 6th. Wells Fargo & Company lifted their target price on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Mizuho set a $102.00 target price on MetLife in a research note on Wednesday, January 14th. Keefe, Bruyette & Woods reduced their price target on MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Finally, UBS Group lowered their price objective on MetLife from $95.00 to $94.00 and set a “buy” rating for the company in a research report on Thursday, January 8th. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $95.27.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.